FMP

FMP

Enter
API Tools
API DocumentationAPI ViewerAPI DocumentationLegacyAPI ViewerLegacy
Pricing
Blog
How To
Education
Index ArticlesForexFinancial RatiosCryptoFinancial AnalysisOther
Market NewsDiscounted Cash FlowDeveloper
Screener
Most Searched StocksForeign Exchange RatesCryptocurrenciesMarket IndexesMarket Top GainersMarket Top LosersMarket Highest VolumeSector Performance
Extras
Resources
Formula Methodologies
Financial FormulasParsing StatementsDCF FormulaPiotroski ScoreOwner EarningsRecommendations Formula
Excel/Sheets Add-on
Excel Add-onGoogle Sheet Add-on
API Updates
ChangelogAPI StatusCycle Times
CareersAffiliate ProgramFAQs
Sign InSign Up

AVTE - Aerovate Therapeutic...

photo-url-https://images.financialmodelingprep.com/symbol/AVTE.png

Aerovate Therapeutics, Inc.

AVTE

NASDAQ

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

2.47 USD

0 (0%)

OverviewProfileFinancial StatementsFinancial RatiosChartAnalysisNewsCorporate ActionsDCF

Valuation Date:

Mar 14, 2025 4:00 PM

Share Price on Valuation Date

$2.47

Stock Beta

1.002

Shares Outstanding

28874500

FMP

FMP

FMP

HomeTerms of ServicePrivacy PolicyBlogCareersFAQsContact Us

API

DocumentationPricingFormulasMarket Indexes
Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep